Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2021 | CVS | Sale | 270,650 | $74.73 | $20.2M |
| Jan 19, 2021 | CVS | Sale | 62,893 | $77.00 | $4.8M |
| Jan 15, 2020 | CVS | Sale | 266,476 | $74.79 | $19.9M |
| Feb 1, 2019 | CVS | Sale | 166,368 | $64.51 | $10.7M |
| Jan 8, 2019 | CVS | Sale | 166,368 | $69.04 | $11.5M |
| Sep 13, 2017 | CVS | Sale | 241,150 | $83.07 | $20.0M |
| Feb 1, 2017 | CVS | Sale | 76,494 | $78.32 | $6.0M |
| May 5, 2016 | CVS | Sale | 38,247 | $105.00 | $4.0M |
| Mar 9, 2016 | CVS | Sale | 38,247 | $100.00 | $3.8M |
| Feb 1, 2016 | CVS | Sale | 46,393 | $96.14 | $4.5M |
| Jan 11, 2016 | CVS | Sale | 46,393 | $95.00 | $4.4M |
SEC reporting-owner ID (CIK) 1194413 · all filings on EDGAR